INCY
Income statement / Annual
Last year (2025), Incyte Corp.'s total revenue was $5.14 B,
an increase of 21.22% from the previous year.
In 2025, Incyte Corp.'s net income was $1.29 B.
See Incyte Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$5.14 B |
$4.24 B |
$3.70 B |
$3.39 B |
$2.99 B |
$2.67 B |
$2.16 B |
$1.88 B |
$1.54 B |
$1.11 B |
| Cost of Revenue |
$372.10 M
|
$312.10 M
|
$254.99 M
|
$207.00 M
|
$150.99 M
|
$131.30 M
|
$114.25 M
|
$94.12 M
|
$79.48 M
|
$58.19 M
|
| Gross Profit |
$4.77 B
|
$3.93 B
|
$3.44 B
|
$3.19 B
|
$2.84 B
|
$2.54 B
|
$2.04 B
|
$1.79 B
|
$1.46 B
|
$1.05 B
|
| Gross Profit Ratio |
0.93
|
0.93
|
0.93
|
0.94
|
0.95
|
0.95
|
0.95
|
0.95
|
0.95
|
0.95
|
| Research and Development Expenses |
$2.05 B
|
$2.61 B
|
$1.63 B
|
$1.59 B
|
$1.46 B
|
$2.22 B
|
$1.15 B
|
$1.20 B
|
$1.33 B
|
$581.86 M
|
| General & Administrative Expenses |
$1.38 B
|
$1.22 B
|
$1.16 B
|
$1.00 B
|
$739.60 M
|
$516.90 M
|
$468.70 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
-$5.64 M
|
$0.00
|
-$40.00 K
|
$0.00
|
$11.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.38 B
|
$1.22 B
|
$1.16 B
|
$1.00 B
|
$739.56 M
|
$516.90 M
|
$468.71 M
|
$434.41 M
|
$366.29 M
|
$303.25 M
|
| Other Expenses |
$0.00
|
-$1.03 M
|
$2.05 M
|
$7.97 M
|
$51.76 M
|
$66.24 M
|
$19.68 M
|
$26.17 M
|
$7.70 M
|
$17.42 M
|
| Operating Expenses |
$3.43 B
|
$3.83 B
|
$2.79 B
|
$2.60 B
|
$2.25 B
|
$2.80 B
|
$1.64 B
|
$1.66 B
|
$1.70 B
|
$902.53 M
|
| Cost And Expenses |
$3.80 B
|
$4.14 B
|
$3.04 B
|
$2.80 B
|
$2.40 B
|
$2.93 B
|
$1.76 B
|
$1.75 B
|
$1.78 B
|
$960.72 M
|
| Interest Income |
$105.60 M
|
$128.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.61 M
|
| Interest Expense |
$2.43 M
|
$2.28 M
|
$2.55 M
|
$2.67 M
|
$1.91 M
|
$2.17 M
|
$1.86 M
|
$1.54 M
|
$6.90 M
|
$38.75 M
|
| Depreciation & Amortization |
$93.29 M
|
$89.25 M
|
$82.66 M
|
$67.86 M
|
$57.84 M
|
$51.81 M
|
$54.53 M
|
$54.97 M
|
$52.18 M
|
$58.43 M
|
| EBITDA |
$1.76 B |
$408.16 M |
$919.43 M |
$599.64 M |
$630.20 M |
-$178.24 M |
$543.18 M |
$171.86 M |
-$253.21 M |
$204.57 M |
| EBITDA Ratio |
0.34
|
0.1
|
0.25
|
0.18
|
0.21
|
-0.07
|
0.25
|
0.09
|
-0.16
|
0.19
|
| Operating Income Ratio |
0.26
|
0.02
|
0.18
|
0.17
|
0.2
|
-0.1
|
0.19
|
0.07
|
-0.16
|
0.13
|
| Total Other Income/Expenses Net |
$321.66 M
|
$215.34 M
|
$178.86 M
|
-$62.51 M
|
-$15.33 M
|
$31.46 M
|
$84.79 M
|
-$13.88 M
|
-$68.90 M
|
-$37.59 M
|
| Income Before Tax |
$1.66 B
|
$316.63 M
|
$834.22 M
|
$529.12 M
|
$570.44 M
|
-$232.22 M
|
$486.79 M
|
$115.35 M
|
-$312.29 M
|
$107.40 M
|
| Income Before Tax Ratio |
0.32
|
0.07
|
0.23
|
0.16
|
0.19
|
-0.09
|
0.23
|
0.06
|
-0.2
|
0.1
|
| Income Tax Expense |
$377.80 M
|
$284.02 M
|
$236.62 M
|
$188.46 M
|
-$378.14 M
|
$63.48 M
|
$39.89 M
|
$5.85 M
|
$852.00 K
|
$3.18 M
|
| Net Income |
$1.29 B
|
$32.62 M
|
$597.60 M
|
$340.66 M
|
$948.58 M
|
-$295.70 M
|
$446.91 M
|
$109.49 M
|
-$313.14 M
|
$104.22 M
|
| Net Income Ratio |
0.25
|
0.01
|
0.16
|
0.1
|
0.32
|
-0.11
|
0.21
|
0.06
|
-0.2
|
0.09
|
| EPS |
6.59 |
0.16 |
2.67 |
1.53 |
4.3 |
-1.36 |
2.08 |
0.52 |
-1.53 |
0.55 |
| EPS Diluted |
6.41 |
0.15 |
2.65 |
1.52 |
4.27 |
-1.36 |
2.05 |
0.51 |
-1.53 |
0.54 |
| Weighted Average Shares Out |
$195.20 M
|
$207.11 M
|
$223.63 M
|
$222.00 M
|
$220.43 M
|
$218.07 M
|
$214.91 M
|
$212.38 M
|
$204.58 M
|
$187.87 M
|
| Weighted Average Shares Out Diluted |
$200.70 M
|
$210.53 M
|
$225.93 M
|
$223.96 M
|
$222.07 M
|
$218.07 M
|
$217.66 M
|
$215.64 M
|
$204.58 M
|
$194.13 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
